ISRG241115P670000
- 0.00
- 0.000.00%
Intuitive Surgical Newsroom
HSBC Raises Intuitive Surgical Price Target to $643 From $586
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating
Intuitive Surgical (ISRG) Gets a Buy From Bank of America Securities
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $550
Argus Adjusts Price Target on Intuitive Surgical to $570 From $520
Morgan Stanley Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $522
Analysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (ITCI), Amylyx Pharmaceuticals Inc (AMLX) and Intuitive Surgical (ISRG)
Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
Mizuho Securities Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $550
A Quick Look at Today's Ratings for Intuitive Surgical(ISRG.US), With a Forecast Between $490 to $550
Intuitive Surgical Is Maintained at In-Line by Evercore ISI Group
RBC Capital Maintains Outperform on Intuitive Surgical, Raises Price Target to $555
A Quick Look at Today's Ratings for Intuitive Surgical(ISRG.US), With a Forecast Between $525 to $555
Intuitive Surgical (ISRG) Gets a Buy From Stifel Nicolaus
Intuitive Surgical Is Maintained at Outperform by Baird
Intuitive Surgical Analyst Ratings
Truist Financial Remains a Buy on Intuitive Surgical (ISRG)
Jefferies Adjusts Price Target on Intuitive Surgical to $475 From $415, Maintains Hold Rating
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Penumbra (PEN)
Baird Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $565